Open access
Locally deployed large language model for real‐world lecanemab eligibility pre‐screening
Carolin Miklitz
Maya Shrestha
Wegner Philipp
Nils Henk
A. Sprinkart
W. Block
J. Luetkens
A. Radbruch
N. Lehnen
Sebastian Nowak
Medicine
Abstract
The introduction of disease‐modifying Alzheimer's therapies requires complex, labor‐intensive patient screening. Cloud‐based large language models (LLMs) could support this task but are often unsuitable for routine care due to data protection constraints.